Hrncir named Pharmacist of the Year by PDS
Published February 2, 2022
"Anyone who knows him understands how well deserved this is"
APC News
Bill Swail passes
Published February 2, 2022
Our condolences to the family and friends of the former APC member.
Press release: FDA concedes in compounding MOU case
Published February 2, 2022
In a significant legal victory for pharmacy compounders, the FDA has conceded it must conduct formal notice-and-comment rulemaking to implement its MOU with states regarding interstate shipments of compounded medications.
Owner Summit fills hotel — but we have an overflow
Published February 2, 2022
If you plan to attend but have not booked a room, we have space at the 10-minutes-away Sonesta ES Suites Scottsdale Paradise Valley.
FTC won’t probe PBMs
Published February 2, 2022
It won't look into their practices without a clearer proposal.
Meta-analysis contradicts faulty NASEM report
Published February 2, 2022
A new paper finds there is simply no evidence that compounded hormones pose an increased clinical risk compared to FDA-approved products.
FDA doubles down on NASEM report
Published February 2, 2022
Lest you think FDA’s threat to restrict compounded hormones (based on that deeply flawed NASEM report) was idle talk, check out the letter the agency sent to 22 members of Congress.
FDA warns about compounded ketamine nasal spray
Published February 2, 2022
It's issued an alert to patients and providers.
The State of the Alliance in 2022
Published February 2, 2022
Where does APC stand? Our leadership explains.
